17 minutes |
Jun 2, 2022
Case Discussion: ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera
16 minutes |
Jun 2, 2022
Clinical Evidence for Omega-3 Polyunsaturated Fatty Acids for Managing ASCVD Risk With Drs. Peter Toth and Pam Taub
19 minutes |
Jun 2, 2022
The Impact of Omega-3 PUFAs on ASCVD Risk Reduction With Drs. Peter Toth and Amit Khera
14 minutes |
Jun 2, 2022
The Role of Inflammation in Atherosclerosis With Drs. Peter Toth and Pam Taub
19 minutes |
Apr 27, 2022
Challenges in Embolic Stroke: Deciding Between Combination Medical and PFO Closure or Medical Management Alone With Drs. Howard Herrmann and John Carroll
17 minutes |
Apr 27, 2022
Challenges in Embolic Stroke: Embolic Stroke Treatment With Drs. Howard Herrmann and John Carroll
14 minutes |
Apr 27, 2022
Challenges in Embolic Stroke: Getting With the Guidelines – PFO Closure and the Use of Medical Therapy With Drs. Howard Herrmann and Scott Kasner
17 minutes |
Apr 27, 2022
Challenges in Embolic Stroke: Confronting Challenges in Diagnosis With Drs. Howard Herrmann and Scott Kasner
15 minutes |
Apr 29, 2021
PFO Closure: Procedural Pearls and Important Considerations with Drs. Herrmann, Carroll, and Kasner
14 minutes |
Apr 29, 2021
Managing Patients With Cryptogenic Stroke: Clinical Perspectives, with Drs. Herrmann, Carroll, and Kasner
15 minutes |
Apr 29, 2021
The Relationship Between PFO and Cryptogenic Stroke: Reviewing the Data, with Drs. Herrmann, Carroll, and Kasner
16 minutes |
Apr 29, 2021
Diagnosis and Classification of Cryptogenic Stroke and PFO-Associated Stroke, with Drs. Herrmann, Carroll, and Kasner
16 minutes |
Mar 24, 2021
Recent Cardiovascular Outcomes Trials: Reducing Triglycerides for Further Risk Reduction with Drs. Pamela Morris and Deepak Bhatt
17 minutes |
Mar 24, 2021
Deep Dive Into Clinical Evidence: Reducing CVD risk through LDL-C reduction with Drs. Pamela Morris and Ann Marie Navar
12 minutes |
Mar 24, 2021
Patient Identification for Residual Risk Management: Who’s At Risk? with Drs. Pamela Morris and Martha Gulati
15 minutes |
Mar 24, 2021
Strategies for Atherosclerotic Cardiovascular Disease (ASCVD) Risk Assessment: What’s the Risk? with Drs. Pamela Morris and Martha Gulati
15 minutes |
Dec 16, 2020
sGC Modulators: Role in Current Treatment Paradigms for Heart Failure With Drs. Paul Armstrong and Javed Butler
15 minutes |
Dec 16, 2020
The Clinical Evidence: Efficacy and Safety of sGC Modulators in Heart Failure With Reduced Ejection Fraction With Drs. Paul Armstrong and Javed Butler